azacitidine has been researched along with HTLV-I Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazanis, E; Benopoulou, O; Diamantopoulos, PT; Meletis, J; Michael, M; Tzeletas, G; Vayopoulos, G; Viniou, NA | 1 |
1 other study(ies) available for azacitidine and HTLV-I Infections
| Article | Year |
|---|---|
Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.
Topics: Anti-Retroviral Agents; Antimetabolites, Antineoplastic; Autoimmune Diseases; Azacitidine; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Polymerase Chain Reaction; Treatment Outcome | 2012 |